-
Diagnostics World News | In a matter of weeks, the COVID-19 pandemic made virtual medical visits the way many if not most physician-patient interactions happen. No one was wholly prepared for the sudden transition from in-person to on-screen visits, but some healthcare organizations were clearly better positioned to make the leap because they had already moved beyond the dabbling stage with the technology.
Jun 18, 2020
-
Diagnostics World News | C2i Genomics closes a series A with a solid cancer monitoring platform out of New York Genome Center and Weill Cornell Medicine. ChromaCode announces another funding round and a high-def PCR test for SARS-CoV-2. Plus more of the latest funding updates from across diagnostics, life sciences, and clinical research.
Jun 17, 2020
-
Diagnostics World News | The necessity of running clinical studies in the midst of a pandemic broke through some of the longstanding fears of sponsors and contract research organizations about the adoption of telehealth technology and the decentralized trial model.
Jun 16, 2020
-
Diagnostics World News | The Association for Molecular Pathology surveyed laboratory professionals offering molecular diagnostic tests for clinical diagnosis of SARS-CoV-2 infection. They released the first findings and recommendations based on that survey last week.
Jun 15, 2020
-
Diagnostics World News | The diagnostics community has continued to expand their understanding of COVID-19, observing the high incidence of cases in certain populations, as well as improving blood tests for the virus.
Jun 12, 2020
-
Diagnostics World News | In recent months, newly published findings on topics such as family history and the role of the gut microbiome continue to shed light on colorectal cancer, and emerging tools like AI-based screening and a “smart toilet” point toward new possibilities.
Jun 9, 2020
-
Diagnostics World News | Research news in COVID-19 diagnostics from China’s CDC and the University of Maryland. New tools and technologies are coming from BioDot, Longhorn, and more.
Jun 5, 2020
-
Diagnostics World News Contributed Commentary | Despite the benefits, the potential of circulating tumor cells (CTCs) to serve as a liquid biopsy for cancer has been underutilized, mostly due to the inability to acquire intact CTCs, along with the associated technical challenges. More importantly, until now, the role of CTC information in the design of oncology clinical trials has been greatly overlooked.
Jun 3, 2020